Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Complement factor B (Homo sapiens (Human)) | BDBM251874 (US9475806, 8-B b) (-)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251876 (US9475806, 9-D b) (-)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251882 (US9475806, 12-D) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251878 (US9475806, 10-B b) (-)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251873 (US9475806, 7-D b) (+)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251887 (US9475806, 17-C) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251870 (US9475806, 6-C b) (-)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251888 (US9475806, 17-G) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251883 (US9475806, 14-I b) (-)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251872 (US9475806, 7-D b) (-)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251869 (US9475806, 5-B b) (-)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251868 (US9475806, 5-B b) (+)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251880 (US9475806, 11-B b) (-)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 295 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251886 (US9475806, 16-G) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 460 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251885 (US9475806, 15-D) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 540 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251871 (US9475806, 6-C b) (+)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 700 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251875 (US9475806, 8-B b) (+)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 720 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251879 (US9475806, 10-B b) (+)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.38E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251877 (US9475806, 9-D b) (+)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.53E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251884 (US9475806, 14-I b) (+)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.35E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM251881 (US9475806, 11-B b) (+)) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.14E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav... | US Patent US9475806 (2016) BindingDB Entry DOI: 10.7270/Q2KS6QG2 | |||||||||||
More data for this Ligand-Target Pair |